Doctor profile · Federal record
Dr. SUKETU NANAVATI, MD
Cardiovascular Disease Physician (CMS: CARDIOVASCULAR DISEASE (CARDIOLOGY)) · Internal Medicine Physician · Nuclear Cardiology Physician · Nuclear Imaging & Therapy Physician · Primary Care Clinic/Center · CAPE MAY COURT HOUSE, NJ
- NPI 1275562811
- 58 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
2 VILLAGE DR
CAPE MAY COURT HOUSE, NJ 082101939
(609) 465-7517
Credentials & registration
- NPI registered
- July 2006 — 20 yrs on file
- Profile last updated
- April 16, 2025
- Year of graduation
- 1968 — 58 yrs since
- Specialty taxonomy
- 207RC0000X — NUCC code
- State licenses (2)
- New Jersey #25MA03564300 · New Jersey #29-28684-02
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1275562811. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
981
Distinct HCPCS
10
Medicare allowed
$109,400
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 299 | 117 | $136 | |
93000 |
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 113 | 93 | $16 | |
93306 |
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 73 | 68 | $95 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 69 | 55 | $188 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 66 | 49 | $96 | |
J2785 |
Injection, regadenoson, 0.1 mg | 59 | 35 | $54 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 43 | 42 | $61 | |
A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose | 34 | 34 | $127 | |
78452 |
Nuclear medicine studies of heart muscle at rest and with stress and spect | 33 | 33 | $487 | |
93880 |
Ultrasound of both sides of head and neck blood flow | 30 | 26 | $212 |
In context: peer comparison
Among 4 peers in this city , average services per provider: 149. This provider delivers 6.6× the peer median.Open Payments
Industry payments received
All-time total
$866
Transactions
26
Manufacturers
13
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $212.32 | |
| AstraZeneca Pharmaceuticals LP | 2 | $186.11 | |
| UCB, Inc. | 1 | $124.85 | |
| ABBVIE INC. | 1 | $113.46 | |
| Novo Nordisk Inc | 3 | $47.56 | |
| Novartis Pharmaceuticals Corporation | 2 | $38.12 | |
| Janssen Pharmaceuticals, Inc | 2 | $31.77 | |
| Merck Sharp & Dohme LLC | 2 | $30.66 | |
| AGEPHA Pharma FZ LLC | 1 | $21.25 | |
| Baxter Healthcare | 1 | $16.78 | |
| WATERMARK MEDICAL, INC. | 1 | $16.66 | |
| Lexicon Pharmaceuticals, Inc. | 1 | $15.07 | |
| CVRx, Inc. | 1 | $10.96 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,371
Patients
401
Total drug cost
$183,150
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Atorvastatin Calcium | Generic | 242 | 74 | $3,303 |
| Rosuvastatin Calcium | Generic | 171 | 51 | $3,069 |
| Carvedilol | Generic | 139 | 46 | $2,019 |
| Torsemide | Generic | 85 | 30 | $1,156 |
| Acebutolol Hcl | Generic | 81 | 18 | $4,471 |
| Labetalol Hcl | Generic | 79 | 18 | $3,727 |
| Valsartan | Generic | 74 | 21 | $2,704 |
| Amlodipine Besylate | Generic | 73 | 22 | $829 |
| Spironolactone-Hctz (Spironolact/Hydrochlorothiazid) | Brand | 72 | 23 | $1,685 |
| Farxiga (Dapagliflozin Propanediol) | Brand | 69 | 18 | $78,387 |